Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,069 | 258 | 81.9% |
| Travel and Lodging | $1,273 | 6 | 17.2% |
| Education | $50.86 | 1 | 0.7% |
| Gift | $15.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,387 | 112 | $0 (2024) |
| Genesys Orthopedics Systems, L.L.C. | $815.08 | 6 | $0 (2023) |
| Daiichi Sankyo Inc. | $622.89 | 48 | $0 (2019) |
| Stimwave Technologies Incorporated | $447.16 | 7 | $0 (2022) |
| Medtronic, Inc. | $375.49 | 7 | $0 (2024) |
| Avanos Medical | $273.47 | 7 | $0 (2021) |
| Purdue Pharma L.P. | $258.29 | 15 | $0 (2018) |
| Nevro Corp. | $243.39 | 7 | $0 (2022) |
| MML US, Inc. | $160.14 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $147.48 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $589.68 | 24 | Abbott Laboratories ($338.50) |
| 2023 | $1,396 | 40 | Genesys Orthopedics Systems, L.L.C. ($815.08) |
| 2022 | $1,902 | 43 | Abbott Laboratories ($1,655) |
| 2021 | $927.04 | 31 | Abbott Laboratories ($488.96) |
| 2020 | $138.39 | 4 | Avanos Medical ($88.42) |
| 2019 | $626.04 | 22 | Abbott Laboratories ($377.46) |
| 2018 | $1,282 | 63 | Daiichi Sankyo Inc. ($477.65) |
| 2017 | $547.02 | 39 | Purdue Pharma L.P. ($221.67) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: Neuromodulation | ||||||
| 11/18/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Neuromodulation | ||||||
| 11/15/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: Neuromodulation | ||||||
| 11/14/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Neuromodulation | ||||||
| 11/06/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Neuromodulation | ||||||
| 11/04/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $29.89 | General |
| Category: Pain Management | ||||||
| 10/16/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $102.13 | General |
| Category: Pain Management | ||||||
| 10/16/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $28.12 | General |
| Category: Pain Management | ||||||
| 10/07/2024 | HydroCision, Inc. | TENJET (Device) | Food and Beverage | In-kind items and services | $73.90 | General |
| Category: Orthopedic & Spine | ||||||
| 10/04/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/01/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Neuromodulation | ||||||
| 09/10/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $4.04 | General |
| Category: Neuromodulation | ||||||
| 08/02/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: Neuromodulation | ||||||
| 05/29/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $2.62 | General |
| Category: Neuromodulation | ||||||
| 05/13/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: Neuromodulation | ||||||
| 05/10/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: Neuromodulation | ||||||
| 04/02/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: Neuromodulation | ||||||
| 04/02/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: Neuromodulation | ||||||
| 03/06/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Neuromodulation | ||||||
| 03/06/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: Neuromodulation | ||||||
| 03/06/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: Neuromodulation | ||||||
| 02/19/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Neuromodulation | ||||||
| 02/06/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $164.18 | General |
| Category: Neuromodulation | ||||||
| 01/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $6.06 | General |
| Category: Neuromodulation | ||||||
| 12/28/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 355 | 764 | $765,463 | $70,064 |
| 2022 | 10 | 381 | 1,025 | $1.2M | $74,008 |
| 2021 | 13 | 468 | 1,369 | $576,210 | $103,291 |
| 2020 | 20 | 1,272 | 3,576 | $652,680 | $168,578 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 401 | $410,528 | $34,644 | 8.4% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 59 | 83 | $150,834 | $16,166 | 10.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 85 | 134 | $64,167 | $8,108 | 12.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 92 | $66,902 | $6,135 | 9.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $37,818 | $3,016 | 8.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $11,773 | $1,020 | 8.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 13 | 13 | $23,442 | $974.46 | 4.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 531 | $659,288 | $47,790 | 7.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 83 | 125 | $59,858 | $7,637 | 12.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $61,116 | $4,261 | 7.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 15 | 26 | $114,506 | $3,815 | 3.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 18 | 28 | $88,671 | $2,618 | 3.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 44 | $38,723 | $2,571 | 6.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2022 | 15 | 44 | $105,896 | $1,989 | 1.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2022 | 16 | 22 | $58,093 | $1,680 | 2.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2022 | 18 | 28 | $46,329 | $1,522 | 3.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 18 | 140 | $672.00 | $125.00 | 18.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 157 | 748 | $297,812 | $72,459 | 24.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 86 | 150 | $71,829 | $9,175 | 12.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $20,220 | $3,746 | 18.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance | Facility | 2021 | 13 | 22 | $40,425 | $3,470 | 8.6% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2021 | 20 | 31 | $43,454 | $3,148 | 7.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 43 | $11,332 | $2,992 | 26.4% |
| 27096 | Injection procedure into sacroiliac joint for anesthetic or steroid | Facility | 2021 | 19 | 25 | $26,969 | $2,086 | 7.7% |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2021 | 19 | 30 | $23,977 | $1,740 | 7.3% |
About Dr. Robert Sutherland, MD
Dr. Robert Sutherland, MD is a Pain Medicine healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1033112933.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Sutherland, MD has received a total of $7,408 in payments from pharmaceutical and medical device companies, with $589.68 received in 2024. These payments were reported across 266 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,069).
As a Medicare-enrolled provider, Sutherland has provided services to 2,476 Medicare beneficiaries, totaling 6,734 services with total Medicare billing of $415,940. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location Tyler, TX
- Active Since 05/24/2005
- Last Updated 10/01/2013
- Taxonomy Code 207LP2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033112933
Products in Payments
- PROCLAIM (Device) $1,949
- SACROILIAC JOINT FUSION SYSTEM (Device) $815.08
- Morphabond ER (Drug) $538.45
- OCTRODE (Device) $475.31
- Proclaim Family of SCS IPGs (Device) $405.20
- Proclaim IPG (Device) $247.01
- Octrode SCS Leads (Device) $218.53
- STANDARD RF DISPOSABLES (Device) $163.79
- ReActiv8 (Device) $160.14
- INTELLIS (Device) $147.87
- MOVANTIK (Drug) $147.48
- Senza Spinal Cord Stimulation System (Device) $135.85
- Vanta (Device) $129.60
- Nucynta (Drug) $112.89
- COOLIEF* COOLED RADIOFREQUENCY (Device) $104.44
- Movantik (Drug) $84.44
- SYMPROIC (Drug) $82.17
- PAIN MANAGEMENT (Device) $80.81
- OXYCONTIN (Drug) $75.87
- TENJET (Device) $73.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Tyler
Obiyo Osuchukwu, Mbbch Mph, MBBCH MPH
Pain Medicine — Payments: $11,540
Scott Burlison, Md, MD
Pain Medicine — Payments: $5,161
Janki Patel, Md, MD
Pain Medicine — Payments: $4,313
Dr. Scott Lamb, M.d, M.D
Pain Medicine — Payments: $2,023
Dr. Chase Culver, M.d, M.D
Pain Medicine — Payments: $1,337
Barbara Sigal, Md, MD
Pain Medicine — Payments: $864.55